Free Trial

Novartis (NVS) Earnings Date, Estimates & Call Transcripts

Novartis logo
$104.28 +0.43 (+0.41%)
(As of 11/22/2024 ET)

Novartis Latest Earnings Summary

Upcoming Q4
Earnings Date
Jan. 29Estimated
Actual EPS
(Oct. 29)
$2.06 Beat By $0.12
Consensus EPS
(Oct. 29)
$1.94

Novartis announced Q3 2024 earnings on October 29, 2024, reporting an EPS of $2.06, which beat analysts' consensus estimates of $1.94 by $0.12. Quarterly revenue was reported to be $12.82 billion, above the consensus estimate of $12.62 billion. With a trailing EPS of $8.61 and a P/E Ratio of 12.11, Novartis' earnings are expected to grow 9.40% next year, from $7.66 to $8.38 per share.

NVS Upcoming Earnings

Novartis' next earnings date is estimated for Wednesday, January 29, 2025, based off prior year's reporting schedules.

Get Novartis Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novartis and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NVS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NVS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Novartis Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$1.71$1.71$1.71 
Q2 20241$1.80$1.80$1.80 
Q3 20241$1.88$1.88$1.88 
Q4 20241$1.76$1.76$1.76 
FY 20244$7.15$7.15$7.15 
Q1 20251$1.94$1.94$1.94 
Q2 20251$2.08$2.08$2.08 
Q3 20251$2.18$2.18$2.18 
Q4 20251$2.02$2.02$2.02 
FY 20254$8.22$8.22$8.22 
Q1 20261$2.06$2.06$2.06 
Q2 20261$2.22$2.22$2.22 
Q3 20261$2.42$2.42$2.42 

Novartis Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
1/29/2025
(Estimated)
------- 
10/29/2024Q3 2024$1.94$2.06+$0.12$2.55$12.62B$12.82B    
7/18/2024Q2 2024$1.87$1.97+$0.10$2.35$12.24B$12.87B    
4/23/2024Q1 2024$1.73$1.80+$0.07$2.29$11.50B$11.83B
1/30/2024Q4 2023$1.64$1.53 -$0.11-$1.08$11.69B$11.42B    
10/23/2023Q3 2023$1.70$1.74+$0.04$2.63$12.05B$11.78B    
7/19/2023Q2 2023$1.68$1.83+$0.15$2.55$6.32M$13.62B    
Nvidia’s world of pain awaits (Ad)

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Click play to stream The Final Frontier at no cost
4/25/2023Q1 2023$1.55$1.71+$0.16$2.34$12.60B$12.95B    
2/1/2023Q4 2022$1.42$1.51+$0.09$2.34$12.85B$12.69B

Novartis Earnings - Frequently Asked Questions

Novartis has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based off last year's report dates. Learn more on NVS's earnings history.

In the previous quarter, Novartis (NYSE:NVS) reported $2.06 earnings per share (EPS) to beat the analysts' consensus estimate of $1.94 by $0.12. Learn more on analysts' earnings estimate vs. NVS's actual earnings.

The conference call for Novartis's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Novartis's latest earnings report can be read online.
Read Transcript

Novartis (NYSE:NVS) has a recorded annual revenue of $45.44 billion.

Novartis (NYSE:NVS) has a recorded net income of $14.85 billion. NVS has generated $8.61 earnings per share over the last four quarters.

Novartis (NYSE:NVS) has a trailing price-to-earnings ratio of 12.11 and a forward price-to-earnings ratio of 13.61. The price/earnings-to-growth ratio is 1.49.

Novartis's earnings are expected to grow from $7.66 per share to $8.38 per share in the next year, which is a 9.40% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:NVS) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners